Annual Retained Earnings
$6.03 B
+$984.80 M+19.53%
31 December 2023
Summary:
United Therapeutics annual retained earnings is currently $6.03 billion, with the most recent change of +$984.80 million (+19.53%) on 31 December 2023. During the last 3 years, it has risen by +$1.71 billion (+39.68%). UTHR annual retained earnings is now at all-time high.UTHR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$6.92 B
+$309.10 M+4.67%
30 September 2024
Summary:
United Therapeutics quarterly retained earnings is currently $6.92 billion, with the most recent change of +$309.10 million (+4.67%) on 30 September 2024. Over the past year, it has increased by +$893.80 million (+14.83%). UTHR quarterly retained earnings is now at all-time high.UTHR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +14.8% |
| 3 y3 years | +39.7% | +60.4% |
| 5 y5 years | +81.3% | +108.1% |
UTHR Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +39.7% | at high | +60.4% |
| 5 y | 5 years | at high | +81.3% | at high | +108.1% |
| alltime | all time | at high | +3178.3% | at high | +3601.8% |
United Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.92 B(+4.7%) |
| June 2024 | - | $6.61 B(+4.4%) |
| Mar 2024 | - | $6.33 B(+5.1%) |
| Dec 2023 | $6.03 B(+19.5%) | $6.03 B(+3.7%) |
| Sept 2023 | - | $5.81 B(+4.8%) |
| June 2023 | - | $5.54 B(+4.9%) |
| Mar 2023 | - | $5.28 B(+4.8%) |
| Dec 2022 | $5.04 B(+16.9%) | $5.04 B(+2.7%) |
| Sept 2022 | - | $4.91 B(+5.1%) |
| June 2022 | - | $4.67 B(+2.5%) |
| Mar 2022 | - | $4.55 B(+5.6%) |
| Dec 2021 | $4.32 B(+12.4%) | $4.32 B(+2.7%) |
| Sept 2021 | - | $4.20 B(+4.0%) |
| June 2021 | - | $4.04 B(+4.5%) |
| Mar 2021 | - | $3.87 B(+0.7%) |
| Dec 2020 | $3.84 B(+15.5%) | $3.84 B(+2.6%) |
| Sept 2020 | - | $3.74 B(+4.8%) |
| June 2020 | - | $3.57 B(+3.1%) |
| Mar 2020 | - | $3.46 B(+4.1%) |
| Dec 2019 | $3.33 B(-3.2%) | $3.33 B(+1.6%) |
| Sept 2019 | - | $3.27 B(+4.2%) |
| June 2019 | - | $3.14 B(+7.0%) |
| Mar 2019 | - | $2.94 B(-14.5%) |
| Dec 2018 | $3.43 B(+20.7%) | $3.43 B(+1.9%) |
| Sept 2018 | - | $3.37 B(+3.3%) |
| June 2018 | - | $3.26 B(+5.6%) |
| Mar 2018 | - | $3.09 B(+8.6%) |
| Dec 2017 | $2.85 B(+16.9%) | $2.85 B(+0.7%) |
| Sept 2017 | - | $2.83 B(+10.8%) |
| June 2017 | - | $2.55 B(-2.1%) |
| Mar 2017 | - | $2.61 B(+7.1%) |
| Dec 2016 | $2.43 B(+41.5%) | $2.43 B(+4.7%) |
| Sept 2016 | - | $2.32 B(+7.5%) |
| June 2016 | - | $2.16 B(+10.5%) |
| Mar 2016 | - | $1.96 B(+13.7%) |
| Dec 2015 | $1.72 B(+61.0%) | $1.72 B(+6.5%) |
| Sept 2015 | - | $1.62 B(+40.4%) |
| June 2015 | - | $1.15 B(+9.4%) |
| Mar 2015 | - | $1.05 B(-1.6%) |
| Dec 2014 | $1.07 B(+46.7%) | $1.07 B(+12.2%) |
| Sept 2014 | - | $952.18 M(-2.6%) |
| June 2014 | - | $977.42 M(+12.9%) |
| Mar 2014 | - | $865.56 M(+18.9%) |
| Dec 2013 | $728.04 M(+31.5%) | $728.04 M(-4.0%) |
| Sept 2013 | - | $758.35 M(+9.0%) |
| June 2013 | - | $695.67 M(+13.0%) |
| Mar 2013 | - | $615.80 M(+11.3%) |
| Dec 2012 | $553.48 M(+122.2%) | $553.48 M(+17.7%) |
| Sept 2012 | - | $470.23 M(+19.9%) |
| June 2012 | - | $392.11 M(+22.6%) |
| Mar 2012 | - | $319.80 M(+28.4%) |
| Dec 2011 | $249.04 M | $249.04 M(+21.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $205.85 M(+69.5%) |
| June 2011 | - | $121.45 M(+155.4%) |
| Mar 2011 | - | $47.56 M(+52.6%) |
| Dec 2010 | $31.17 M(-141.7%) | $31.17 M(+44.1%) |
| Sept 2010 | - | $21.63 M(-219.4%) |
| June 2010 | - | -$18.11 M(-67.6%) |
| Mar 2010 | - | -$55.82 M(-25.3%) |
| Dec 2009 | -$74.75 M(-20.4%) | -$74.75 M(+5.1%) |
| Sept 2009 | - | -$71.14 M(-14.4%) |
| June 2009 | - | -$83.07 M(+4.1%) |
| Mar 2009 | - | -$79.78 M(-15.1%) |
| Dec 2008 | -$93.93 M(+336.8%) | -$93.93 M(-657.3%) |
| Sept 2008 | - | $16.86 M(+298.3%) |
| June 2008 | - | $4.23 M(-141.9%) |
| Mar 2008 | - | -$10.10 M(-53.0%) |
| Dec 2007 | -$21.50 M(-48.0%) | -$21.50 M(-8.5%) |
| Sept 2007 | - | -$23.49 M(-38.7%) |
| June 2007 | - | -$38.34 M(-13.2%) |
| Mar 2007 | - | -$44.14 M(+6.7%) |
| Dec 2006 | -$41.36 M(-64.1%) | -$41.36 M(-57.3%) |
| Sept 2006 | - | -$96.87 M(-8.0%) |
| June 2006 | - | -$105.34 M(-6.8%) |
| Mar 2006 | - | -$113.02 M(-2.0%) |
| Dec 2005 | -$115.33 M(-36.1%) | -$115.33 M(-20.3%) |
| Sept 2005 | - | -$144.74 M(-9.8%) |
| June 2005 | - | -$160.50 M(-7.1%) |
| Mar 2005 | - | -$172.68 M(-4.2%) |
| Dec 2004 | -$180.34 M(-7.9%) | -$180.34 M(-3.7%) |
| Sept 2004 | - | -$187.23 M(-3.2%) |
| June 2004 | - | -$193.50 M(-2.1%) |
| Mar 2004 | - | -$197.64 M(+0.9%) |
| Dec 2003 | -$195.79 M(+5.4%) | -$195.79 M(+1.7%) |
| Sept 2003 | - | -$192.57 M(+0.7%) |
| June 2003 | - | -$191.23 M(+1.3%) |
| Mar 2003 | - | -$188.84 M(+1.6%) |
| Dec 2002 | -$185.82 M(+14.6%) | -$185.82 M(+1.4%) |
| Sept 2002 | - | -$183.22 M(+7.1%) |
| June 2002 | - | -$171.03 M(+1.9%) |
| Mar 2002 | - | -$167.85 M(+3.5%) |
| Dec 2001 | -$162.17 M(+29.9%) | -$162.17 M(+4.8%) |
| Sept 2001 | - | -$154.74 M(+6.8%) |
| June 2001 | - | -$144.93 M(+7.9%) |
| Mar 2001 | - | -$134.28 M(+7.5%) |
| Dec 2000 | -$124.88 M(+153.3%) | -$124.88 M(+34.3%) |
| Sept 2000 | - | -$93.01 M(+8.2%) |
| June 2000 | - | -$86.00 M(+50.4%) |
| Mar 2000 | - | -$57.19 M(+16.0%) |
| Dec 1999 | -$49.30 M(+212.0%) | -$49.30 M(+21.7%) |
| Sept 1999 | - | -$40.50 M(+18.8%) |
| June 1999 | - | -$34.10 M(+21.8%) |
| Mar 1999 | - | -$28.00 M |
| Dec 1998 | -$15.80 M | - |
FAQ
- What is United Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for United Therapeutics?
- What is United Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for United Therapeutics?
- What is United Therapeutics quarterly retained earnings year-on-year change?
What is United Therapeutics annual retained earnings?
The current annual retained earnings of UTHR is $6.03 B
What is the all time high annual retained earnings for United Therapeutics?
United Therapeutics all-time high annual retained earnings is $6.03 B
What is United Therapeutics quarterly retained earnings?
The current quarterly retained earnings of UTHR is $6.92 B
What is the all time high quarterly retained earnings for United Therapeutics?
United Therapeutics all-time high quarterly retained earnings is $6.92 B
What is United Therapeutics quarterly retained earnings year-on-year change?
Over the past year, UTHR quarterly retained earnings has changed by +$893.80 M (+14.83%)